Latest "Fred’s Pharmacy" News Stories

15:31 EST 14th December 2017 | BioPortfolio

Here are the most relevant search results for "Fred’s Pharmacy" found in our extensive news archives from over 250 global news sources.

More Information about Fred’s Pharmacy on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Fred’s Pharmacy for you to read. Along with our medical data and news we also list Fred’s Pharmacy Clinical Trials, which are updated daily. BioPortfolio also has a large database of Fred’s Pharmacy Companies for you to search.

Showing "Fred Pharmacy" News Articles 1–25 of 1,700+

Thursday 14th December 2017

New Results from Annual Survey Show Teen Misuse of OTC Cough Medicine Remains Very Low

The 2017 results from the National Institute on Drug Abuse (NIDA) and University of Michigan’s annual drug abuse survey, Monitoring the Future, were released today showing that 

Humana Partners with Gym Farm to Enhance Customer Experience Offered to Members of Reward-based Wellness Program

A majority of the 4.9 million members of Humana Inc.’s reward-based wellness program, Go365, will now earn rewards quicker through daily tracking and reporting of fitness check-ins and at more participating health centers thanks to a partnership with Gym Farm’s Health Data Network, a San Francisco-based health and wellness software automation technolog...

Advocate Health Network Goes Live with Caradigm Knowledge Hub and Caradigm Care Management

Improves Patient Outcomes and Care Efficiency for its High-Risk Patient Populations Caradigm®, the leader in enterprise population health, today announced that Advocate Health Network (AHN), the Accountable Care Organization (ACO)

Elemeno Health Closes $1.3 Million in Seed Round Led by Launchpad Digital Health

Virtual Coach Empowers Frontline Healthcare Staff to Deliver Quality and Safety Elemeno Health announced today that it has completed a $1.3 million seed round led by Launchpad Digital Health. The finan

Cibiem Appoints William H. Kucheman to the Board of Directors

Cibiem, Inc., a clinical-stage medical device company targeting the carotid body to treat diseases like hypertension and heart failure, today announced that industry veteran William H. (Hank) Kucheman has joined its board of directors. Mr. Kucheman’s addition expands Cibiem’s number of directors to seven as he joins independent directors Fred Khosravi ...

Jamieson Wellness Inc. Closes 2017 with Industry Recognitions

Jamieson Wellness Recognized as Best Partner by London Drugs and; National Nutrition Awards Recognize Jamieson Wellness People and Products in Multiple Categories Jamieson Wellness Inc. (“Jamieson Wellness” or the “Company”) (TSX:JWEL), Canada’s number one manufacturer and marketer of branded vitamins, minerals and supplements, has re...

Top five benefits of real-world evidence in the healthcare industry

Quantzig, a global analytics solutions provider, has announced the completion of their latest analysis on the top five reasons why you need real world evidence. Real world evidence removes the limits of randomized clinical trials (RCT) by offering insights into the performance of various drugs and their uses in a real-world setup. This press releas...

bioMérieux, Inc. and McKesson Medical-Surgical Announce Distribution Alliance

McKesson Medical-Surgical Inc., an affiliate of the McKesson Corporation, has signed an exclusive agreement with bioMérieux, Inc. to serve the U.S. community hospital market. The agreement highlights the two companies’ shared focus on antibiotic stewardship and preventing sepsis in hospital care settings by delivering better solutions for healthcare pro...

iMedicare and Creative Pharmacist Announce Strategic Partnership

Brings innovation together to empower enhanced services networks iMedicare, the leading decision automation platform for pharmacies, and Creative Pharmacist, developer of the STRAND® Intervention Platform and the market leader in supporting clinical services offered by community pharma

Humana Announces $3 Billion Share Repurchase Authorization

Humana Inc. (NYSE: HUM) announced today that its Board of Directors has approved a $3 billion share repurchase authorization with an expiration date of December 31, 2020, replacing its previous $2.25 billion share repurchase authorization, which has no further capacity. The company may repurchase shares from time to time at prevailing prices in the open ma...

Gilbane Building Company Receives Merit Award for Excellence in Construction for Duke University Student Wellness Center

The Associate Builders and Contractors of the Carolinas (ABC) recognized the Student Wellness Center with a Merit Award at their annual ceremony DURHAM, N.C. (PRWEB) December 14, 2017 Gilbane Building Company, a leader in higher education construction, received a Merit award for the construction of the Duke University Student Wellness Center in Durham, North Carolina from Associated Builders and ...

Brigham and Women's Hospital Medical Equipment Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryBrigham and Women's Hospital BWH is a healthcare service provider that offers patient care services. The hospital offers care coordination, ethics consultation, interpreter services, Kessler library, nutrition, patient and family relations, pharmacy, security and safety, and spiritual care services. It offers services in the areas of anesthesiology, cancer, dermatology, emergency medicine, ...

Wednesday 13th December 2017

Getting on track with wearables

Michael JohnsenWith big retailers and brands cornering the market, pharmacy retailers look for a slice of the burgeoning wearables market. read more implements Innovation’s PharmASSIST

David SalazarInnovation’s PharmASSIST Quick Start high volume technology has been chosen by for use in its online/mail-order pharmacy in Florence, Ky.   read more

Anesthesia Business Consultants Announces Quality Touch from Plexus TG Now Available to All MiraMed Registry Participants

Anesthesia Business Consultants (ABC), a leading provider in billing and practice management for the anesthesia and pain management specialty, along with affiliate company

MJH Studios™ Featured in Post Magazine

The article shines the spotlight on MJH Studios™ state-of-the-art production facility. MJH Studios™, a world-class production facility and resource center dedicated to the creation and distribution of original content, was recently featured in Post Magazine. The article highlights the successful growth of the studio and its ability to offer a super...

Walgreens Flu Index™ for Week Ending December 9, 2017

For the second consecutive week, Brownsville and Beaumont, Texas top the Index list for flu activity The Walgreens Flu Index™ is a weekly report developed to provide state- and market-specific information regarding flu activity, and ranks those states and markets experiencing the highest incidences of influenza across the country. This p...

Survey Finds Insurance Companies are Forcing Massachusetts Patients Off Prescribed Medications During the Plan Year, Providing A Need for New Legislation to Fix the Problem

Nearly all respondents (94%) support legislation prohibiting insurance companies from financially pressuring them to switch from their prescribed medication A coalition of 19 patient and provider organizations known as the Massachusetts Patient Access and Safety Coalition today released results of a survey showing that a majority of those in Massachuse...

56 Percent of Consumers Don’t Know Obamacare Open Enrollment Ends This Friday

More than one-third of surveyed eHealth customers eligible for subsidies report paying $100 or less per month for coverage; the same percentage of unsubsidized consumers are paying $1,000 or more. As the Obamacare open enrollment period enters its final days, a new survey by eHealth, Inc. (NASDAQ: EHTH) ( finds that 56 percent of consumers ...

The Medicines Company to Host Investor Day on January 23, 2018

The Medicines Company (NASDAQ:MDCO) today announced that it will host an Investor Day on Tuesday, January 23, 2018, from 10:00 a.m. to 12:30 p.m., Eastern Time, in New York City. The event will be led by Fred Eshelman, Pharm.D., Executive Chairman of The Medicines Company, and Clive Meanwell, M.D., Ph.D., Chief Executive Officer of the Company, wh...

Apexus Training for 340B Prime Vendor Program Wins AXIS Award for Education

Apexus, a national leader on the 340B Drug Pricing Program, received an AXIS Award for excellence in education and training from the Dallas Chapter of the Association for Talent Development. The AXIS Award celebrates excellent work in talent development at non-profit organizations, small business and large corporations in the Dallas/Fort Wo...

Record number of children starting school overweight is branded ‘scandalous’ – HeraldScotland

HeraldScotlandRecord number of children starting school overweight is branded 'scandalous'HeraldScotlandA RECORD number of children in Scotland are overweight or obese when they start primary school, with youngsters from the poorest areas most at risk. The latest figures were condemned as “scandalous” and a “ticking timebomb”. by health experts, who ...Childhood obesity 'getting worse ever...

Tuesday 12th December 2017

Dennis Wiesner’s ever-evolving industry career

Seth MendelsonDSN bestows 2017 Pharmacy Innovator Award to Dennis Wiesner. read more

Health Professions Education Leaders Share Strategies, Tools and Support to Advance Collaboration Across the Health Professions

Inaugural IPEC Interprofessional Deans' Leadership Program Convenes in Washington, DC Last week’s inaugural Interprofessional Education Collaborative (IPEC) Interprofessional Deans’ Leadership Program (IDLP) engaged 42 deans and senior academic leaders across 15 IPEC member associations’ schools from across the health professions. This thr...

Juno Therapeutics Highlights Data and Presentations Supporting Best-in-Class Strategy for JCAR017 at ASH

—Updated JCAR017 (liso-cel) data in core group at dose level 2 showed 74% (14/19) ORR and 68% (13/19) CR rate at 3 months, with 50% (7/14) CR at 6 months— —JCAR017 data continue to support better responses at dose level 2 without increased toxicity observed for CRS and NT compared to dose level 1 in core group— Juno Therapeutics...

Quick Search

News Quicklinks